Cargando…
Current Smoking Does Not Modify the Treatment Effect of Intravenous Thrombolysis in Acute Ischemic Stroke Patients—A Post-hoc Analysis of the WAKE-UP Trial
Background: The “smoking paradox” indicates that patients with acute ischemic stroke (AIS) who smoke at the time of their stroke may have a better prognosis after intravenous thrombolysis than non-smokers. However, findings are inconsistent and data analyzing the effect of smoking on treatment effic...
Autores principales: | Schlemm, Ludwig, Kufner, Anna, Boutitie, Florent, Nave, Alexander Heinrich, Gerloff, Christian, Thomalla, Götz, Simonsen, Claus Z., Ford, Ian, Lemmens, Robin, Muir, Keith W., Nighoghossian, Norbert, Pedraza, Salvador, Ebinger, Martin, Endres, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883001/ https://www.ncbi.nlm.nih.gov/pubmed/31824412 http://dx.doi.org/10.3389/fneur.2019.01239 |
Ejemplares similares
-
Post-hoc Analysis of Outcome of Intravenous Thrombolysis in Infarcts of Infratentorial Localization in the WAKE-UP Trial
por: Galinovic, Ivana, et al.
Publicado: (2019) -
Clinical Characteristics and Outcome of Patients With Hemorrhagic Transformation After Intravenous Thrombolysis in the WAKE-UP Trial
por: Jensen, Märit, et al.
Publicado: (2020) -
Extent of FLAIR Hyperintense Vessels May Modify Treatment Effect of Thrombolysis: A Post hoc Analysis of the WAKE-UP Trial
por: Grosch, Anne Sophie, et al.
Publicado: (2021) -
Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke: An Analysis of the WAKE-UP Randomized Clinical Trial
por: Schlemm, Ludwig, et al.
Publicado: (2022) -
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial
por: Frey, Benedikt M., et al.
Publicado: (2020)